| Selective reactivation of STING signaling to target Merkel cell carcinoma W Liu, GB Kim, NA Krump, Y Zhou, JL Riley, J You Proceedings of the National Academy of Sciences 117 (24), 13730-13739, 2020 | 40 | 2020 |
| Challenges and opportunities of using adoptive T-Cell therapy as part of an HIV cure strategy Y Zhou, CR Maldini, J Jadlowsky, JL Riley The Journal of Infectious Diseases 223 (Supplement_1), S38-S45, 2021 | 17 | 2021 |
| Discovery and Engineering of a Therapeutic Interfering Particle (TIP): a combination self-renewing antiviral EJ Tanner, SY Jung, J Glazier, C Thompson, Y Zhou, B Martin, HI Son, ... bioRxiv, 820456, 2019 | 8 | 2019 |
| Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas Y Fang, Y Zhou, Y Zhang, L He, C Xue, Y Cao Oncotarget 9 (3), 3842, 2018 | 8 | 2018 |
| Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells Y Zhou, J Jadlowsky, C Baiduc, AW Klattenhoff, Z Chen, AD Bennett, ... PLoS pathogens 19 (12), e1011853, 2023 | 1 | 2023 |
